Clinical trials: "Registry-embedded clinical trials are the way of the future"

Interview with Prof. Edmund Neugebauer, Head of the Institute of Research in Operative Medicine (IFOM), University Witten/Herdecke

Even medical risk products are not always tested as thoroughly as would be necessary – be it because of criminal energy, lack of know-how or financial reasons. A revision of clinical trial procedures could not only fix loop holes and methodological flaws. Products and methods could also be brought into general medical care more quickly under new rules.


Photo: Prof. Edmund Neugebauer

Prof. Edmund Neugebauer; © private

Graphic: Four stair landings with doors above each other

This could be the future of clinical trials for medical risk products: a multi-staged process that is completely documented in a registry; © Milosh Kojadinovich

Photo: Training of medical staff

Manufacturers can well be integrated into studies. They can support health care providers - hospital staff and physicians - with know-how and train them in the handling of a new device; ©

Photo: Timo Roth; Copyright: B. Frommann

© B. Frommann